720
Views
25
CrossRef citations to date
0
Altmetric
Review

Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders

&
Pages 841-850 | Received 27 Apr 2017, Accepted 27 Jul 2017, Published online: 09 Aug 2017

References

  • Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(11):1107–1115.
  • Diaz FJ, Velásquez DM, Susce MT, et al. The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period. Schizophr Res. 2008;104(1):214–219.
  • Diaz FJ, James D, Botts S, et al. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disorders. 2009;11(2):154–165.
  • Kleber HD, Anton RF Jr, George TP, et al. Treatment of patients with substance use disorders. In: American Psychiatric Association Practice Guidelines for the treatment of psychiatric disorders: compendium 2006. Arlington, Virginia: American Psychiatric Association. 2006. p. 291.
  • Parks J, Jewell P, Maile Burke M. Technical report on smoking policy and treatment in state operated psychiatric facilities. Editors: Parks J, and Jewell P. In: National Association of State Mental Health Program Directors. Alexandria (VA): Medical Directors Council. 2006.
  • Fu SS, McFall M, Saxon AJ, et al. Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res. 2007;9(11):1071–1084.
  • Klungsøyr O, Nygård JF, Sørensen T, et al. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am J Epidemiol. 2006;163(5):421–432.
  • Eriksen M, Mackay J, Schluger N, et al. The tobacco atlas. 5th ed. revised, expanded and updated. Atlanta (GA): American Cancer Society; 2015.
  • McClave AK, McKnight-Eily LR, Davis SP, et al. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am J Public Health. 2010;100(12):2464–2472.
  • Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606–2610.
  • Bowden JA, Miller CL, Hiller JE. Smoking and mental illness: a population study in South Australia. Aust NZ J Psychiatry. 2011;45(4):325–331.
  • Sung H-Y, Prochaska JJ, Ong MK, et al. Cigarette smoking and serious psychological distress: a population-based study of California adults. Nicotine Tob Res. 2011;13(12):1183–1192.
  • Gierisch JM, Bastian LA, Calhoun PS, et al. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J Gen Intern Med. 2012;27(3):351–360.
  • Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004;72(6):1144–1156.
  • Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297–314.
  • US Department of Health Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. p. 17.
  • Prochaska JJ, Gill P, Hall SM. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv. 2004;55(11):1265–1270.
  • Oquendo MA, Galfalvy H, Russo S, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry. 2004;161(8):1433–1441.
  • Breslau N, Schultz LR, Johnson EO, et al. Smoking and the risk of suicidal behavior: a prospective study of a community sample. Arch Gen Psychiatry. 2005;62(3):328–334.
  • Balbuena L, Tempier R. Independent association of chronic smoking and abstinence with suicide. Psychiatric Services. 2015;66(2):186–192.
  • Clarke DE, Eaton WW, Petronis KR, et al. Increased risk of suicidal ideation in smokers and former smokers compared to never smokers: evidence from the Baltimore ECA follow-up study. Suicide Life Threat Behav. 2010;40(4):307–318.
  • Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control. 2004;13(2):206–206.
  • Montoya ID, Herbeck DM, Svikis DS, et al. Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. Am J Addict. 2005;14(5):441–454.
  • Stuber J, Galea S, Link BG. Smoking and the emergence of a stigmatized social status. Soc Sci Med. 2008;67(3):420–430.
  • Prochaska JJ, Fletcher L, Hall SE, et al. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict. 2006;15(1):15–22.
  • Farley SM, Waddell EN, Coady MH, et al. Correlates of smoke-free housing policies and interest in implementing policies among multiunit housing owners in New York City. J Urban Health. 2015;92(2):291–303.
  • Prochaska JJ, Michalek AK, Brown-Johnson C, et al. Likelihood of unemployed smokers vs nonsmokers attaining reemployment in a one-year observational study. JAMA Intern Med. 2016;176(5):662–670.
  • Bandiera FC, Arheart KL, Caban-Martinez AJ, et al. Secondhand smoke exposure and depressive symptoms. Psychosom Med. 2010;72(1):68.
  • Bandiera FC, Richardson AK, Lee DJ, et al. Secondhand smoke exposure and mental health among children and adolescents. Arch Pediatr Adolesc Med. 2011;165(4):332–338.
  • Okoli CT, Khara M. Correlates of secondhand tobacco smoke exposure among individuals with a history of substance use and/or psychiatric disorders participating in a tobacco treatment program in Vancouver, Canada. Community Ment Health J. 2014;50(6):729–736.
  • Acquavita SP, McClure EA, Hargraves D, et al. Environmental tobacco smoke exposure among smokers and non-smokers receiving outpatient substance abuse treatment. Addict Behav. 2014;39(12):1718–1722.
  • Brown-Johnson CG, Sanders-Jackson A, Prochaska JJ. Online comments on smoking bans in psychiatric hospitals units. J Dual Diagn. 2014;10(4):204–211.
  • Cohen B, McGinnis S, Salsberg E. Physician behavior and practice patterns related to smoking cessation. Washington (DC): Association of American Medical Colleges; 2007.
  • Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. Aust NZ J Psychiatry. 2005;39(10):866–885.
  • Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophrenia Bulletin. 2008;34(3):555–567.
  • Evins AE, Cather C, Culhane MA, et al. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007;27(4):380–386.
  • Prochaska JJ, Hall SE, Delucchi K, et al. Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health. 2014;104(8):1557–1565.
  • Das S, Hickman NJ, Prochaska JJ. Treating Smoking in Adults With Co-occurring Acute Psychiatric and Addictive Disorders. Journal of Addiction Medicine 2017;11(4):273–279.
  • Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction. 2009;104(5):719–733.
  • Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–2520.
  • Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2010;6(6).
  • Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction. 2010;105(7):1176–1189.
  • Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;5:Cd006103.
  • Stead LF, Koilpillai P, Fanshawe TR, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Lib. 2016.
  • Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline. Rockville (MD): US Department of Health and Human Services; 2000. p. 00–0032.
  • Stead LF, Koilpillai P, Lancaster T. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Lib. 2015.
  • Aubin HJ, Luquiens A, Berlin I. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol. 2014;77(2):324–336.
  • Prochaska JJ, Das S, Benowitz NL. Cytisine, the world’s oldest smoking cessation aid. BMJ. 2013;347:f5198.
  • Alsharari SD, Siu EC, Tyndale RF, et al. Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor. Nicotine Tob Res. 2014;16(1):18–25.
  • Tejeda HA, Natividad LA, Orfila JE, et al. Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner. Psychopharmacology (Berl). 2012;224(2):289–301.
  • Beard E, Shahab L, Cummings DM, et al. New pharmacological agents to aid smoking cessation and tobacco harm reduction: what has been investigated, and what is in the pipeline? CNS Drugs. 2016;30(10):951–983.
  • Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 2007;16(1):36–49.
  • Chen L-S, Baker TB, Jorenby D, et al. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. Drug Alcohol Depend. 2015;154:278–282.
  • Hughes JR, Gust SW, Skoog K, et al. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry. 1991;48(1):52–59.
  • Hickman NJ, Delucchi KL, Prochaska JJ. Treating tobacco dependence at the intersection of diversity, poverty, and mental illness: a randomized feasibility and replication trial. Nicotine Tob Res. 2015;17(8):1012–1021.
  • Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Lib. 2013.
  • Lindson-Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2015;(3):CD006936.
  • Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry. 2006;14(4):212–222.
  • Barth J, Jacob T, Daha I, et al. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev. 2015;(7):CD006886.
  • Roberts E, Eden Evins A, McNeill A, et al. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction. 2016;111(4):599–612.
  • Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;3:Cd001292.
  • Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: the process and practice of mindful change. New York: Guilford Press. 2011.
  • Lee EB, An W, Levin ME, et al. An initial meta-analysis of acceptance and commitment therapy for treating substance use disorders. Drug Alcohol Depend. 2015;155:1–7.
  • Khoury B, Lecomte T, Fortin G, et al. Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev. 2013;33(6):763–771.
  • Cristea IA, Gentili C, Cotet CD, et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(4):319–328.
  • Kelly MM, Sido H, Forsyth JP, et al. Acceptance and commitment therapy smoking cessation treatment for veterans with posttraumatic stress disorder: a pilot study. J Dual Diagn. 2015;11(1):50–55.
  • Meyers L, Voller EK, McCallum EB, et al. Treating veterans with PTSD and borderline personality symptoms in a 12-week intensive outpatient setting: findings from a pilot program. J Trauma Stress. 2017;30(2):178–181.
  • Shoptaw S, Rotheram‐Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction. 2002;97(10):1317–1328.
  • Burling TA, Seidner Burling A, Latini D. A controlled smoking cessation trial for substance-dependent inpatients. J Consult Clin Psychol. 2001;69(2):295–304.
  • Rohsenow DJ, Martin RA, Tidey JW, et al. Treating smokers in substance treatment with contingent vouchers, nicotine replacement and brief advice adapted for sobriety settings. J Subst Abuse Treat. 2017;72:72–79.
  • Stead LF, Hartmann‐Boyce J, Perera R, et al. Telephone counselling for smoking cessation. Cochrane Lib. 2013.
  • Saul J, Davis R, North American Quitline Consortium. Results from the 2012 NAQC Annual Survey of Quitlines [Internet]. Jul 2013. [cited 2017 August]. Available from: https://c.ymcdn.com/sites/www.naquitline.org/resource/resmgr/2012_annual_survey/oct23naqc_2012_final_report_.pdf
  • Zhang L, Malarcher A, Babb S, et al. The impact of a national tobacco education campaign on state-specific quitline calls. Am J Health Promot. 2016;30(5):374–381.
  • Rogers ES, Smelson DA, Gillespie CC, et al. Telephone smoking-cessation counseling for smokers in mental health clinics: a patient-randomized controlled trial. Am J Prev Med. 2016;50(4):518–527.
  • Morris CD, Burns EK, Waxmonsky JA, et al. Smoking cessation behaviors among persons with psychiatric diagnoses: results from a population-level state survey. Drug Alcohol Depend. 2014;136:63–68.
  • Borrelli B, Bartlett YK, Tooley E, et al. Prevalence and frequency of mHealth and eHealth use among US and UK smokers and differences by motivation to quit. J Med Internet Res. 2015;17(7):e164.
  • Civljak M, Stead LF, Hartmann‐Boyce J, et al. Internet-based interventions for smoking cessation. Cochrane Lib. 2013.
  • Hunt YM. Self-reported quit rates among users of a national text message based cessation program: early data from the national cancer institute’s smokefreetxt. In Society for Research on Nicotine and Tobacco. (Ed.^(Eds). Boston (MA); 2013.
  • Spohr SA, Nandy R, Gandhiraj D, et al. Efficacy of SMS text message interventions for smoking cessation: a meta-analysis. J Subst Abuse Treat. 2015;56:1–10.
  • Abroms LC, Boal AL, Simmens SJ, et al. A randomized trial of Text2Quit: a text messaging program for smoking cessation. Am J Prev Med. 2014;47(3):242–250.
  • Whittaker R, Borland R, Bullen C, et al. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2009;4(4).
  • BinDhim NF, McGeechan K, Trevena L. Who uses smoking cessation apps? A feasibility study across three countries via smartphones. JMIR mHealth uHealth. 2014;2(1):e4.
  • Garrison KA, Pal P, Rojiani R, et al. A randomized controlled trial of smartphone-based mindfulness training for smoking cessation: a study protocol. BMC Psychiatry. 2015;15(1):83.
  • Stoyanov SR, Hides L, Kavanagh DJ, et al. Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR mHealth uHealth. 2015;3(1):e27.
  • Raiff BR, Jarvis BP, Rapoza D. Prevalence of video game use, cigarette smoking, and acceptability of a video game–based smoking cessation intervention among online adults. Nicotine Tob Res. 2012;14(12):1453–1457.
  • Abroms LC, Padmanabhan N, Thaweethai L, et al. iPhone apps for smoking cessation: a content analysis. Am J Prev Med. 2011;40(3):279–285.
  • Krebs P, Burkhalter JE, Snow B, et al. Development and alpha testing of QuitIT: an interactive video game to enhance skills for coping with smoking urges. JMIR Res Protoc. 2013;2(2):e35.
  • Ramo DE, Liu H, Prochaska JJ. A mixed-methods study of young adults’ receptivity to using Facebook for smoking cessation: if you build it, will they come? Am J Health Promot. 2015;29(4):e126–e135.
  • Cobb NK, Jacobs MA, Saul J, et al. Diffusion of an evidence-based smoking cessation intervention through Facebook: a randomised controlled trial study protocol. BMJ Open. 2014;4(1):e004089.
  • Pechmann C, Delucchi K, Lakon CM, et al. Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention. Tobacco Control. 2017;26:188–194.
  • Rigotti NA. e-Cigarette use and subsequent tobacco use by adolescents: new evidence about a potential risk of e-cigarettes. JAMA. 2015;314(7):673–674.
  • Dutra LM, Grana R, Glantz SA. Philip Morris research on precursors to the modern e-cigarette since 1990. Tobacco Control .2016. tobaccocontrol-2016-053406.
  • Giovenco DP, Hammond D, Corey CG, et al. E-cigarette market trends in traditional US retail channels, 2012–2013. Nicotine Tob Res. 2014;17(10):1279–1283.
  • Leventhal AM, Strong DR, Kirkpatrick MG, et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA. 2015;314(7):700–707.
  • Cummins SE, Zhu S-H, Tedeschi GJ, et al. Use of e-cigarettes by individuals with mental health conditions. Tobacco Control .2014. tobaccocontrol-2013-051511.
  • Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLoS One. 2014;9(11):e113013.
  • Hess I, Lachireddy K, Capon A. A systematic review of the health risks from passive exposure to electronic cigarette vapour. Public Health Res Pract. 2016;26(2):e2621617.
  • Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014. New England Journal of Medicine. 2017;376:342–353.
  • Goniewicz ML, Gupta R, Lee YH, et al. Nicotine levels in electronic cigarette refill solutions: a comparative analysis of products from the US, Korea, and Poland. Int J Drug Policy. 2015;26(6):583–588.
  • Hartmann-Boyce J, McRobbie H, Bullen C, et al. Electronic cigarettes for smoking cessation. Cochrane Lib. 2016.
  • Bhatnagar A, Whitsel LP, Ribisl KM, et al. Electronic cigarettes. Circulation. 2014;130(16):1418–1436.
  • Benowitz NL, Henningfield JE. Establishing a Nicotine Threshold for Addiction – The Implications for Tobacco Regulation. New England Journal of Medicine. 1994;331(2):123–125.
  • Tidey JW, Pacek LR, Koopmeiners JS, et al. Effects of 6-week use of reduced-nicotine content cigarettes in smokers with and without elevated depressive symptoms. Nicotine Tob Res. 2017;19(1):59-67.
  • Hammond D, O’Connor RJ. Reduced nicotine cigarettes: smoking behavior and biomarkers of exposure among smokers not intending to quit. Cancer Epidemiol Prev Biomarkers. 2014;23(10):2032–2040.
  • Mercincavage M, Souprountchouk V, Tang KZ, et al. A randomized controlled trial of progressively reduced nicotine content cigarettes on smoking behaviors, biomarkers of exposure, and subjective ratings. Cancer Epidemiol Prev Biomarkers. 2016;25(7):1125–1133.
  • Allen SI, Foulds J, Pachas GN, et al. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. BMC Public Health. 2017;17(1):100.
  • Donny EC, Hatsukami DK. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2016;374(4):396–397.
  • Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343–355.
  • Auer R, Concha-Lozano N, Jacot-Sadowski I, et al. Heat-not-burn tobacco cigarettes: smoke by any other name. JAMA Intern Med. 2017;177:1050.
  • Farsalinos KE, Yannovits N, Sarri T, et al. Nicotine delivery to the aerosol of a heat-not-burn tobacco product: comparison with a tobacco cigarette and e-cigarettes. Nicotine Tob Res. 2017.
  • Available from: http://www.healthypeople.gov/
  • Prochaska JJ, Fromont SC, Leek D, et al. Evaluation of an evidence-based tobacco treatment curriculum for psychiatry residency training programs. Acad Psychiatry. 2008;32(6):484–492.
  • Metse AP, Wiggers JH, Wye PM, et al. Smoking and mental illness: a bibliometric analysis of research output over time. Nicotine Tob Res. 2017;19(1):24–31.
  • Lembke A, Humphreys K. A call to include people with mental illness and substance use disorders alongside ‘regular’ smokers in smoking cessation research. Tob Control. 2016;25(3):261–262.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.